Global Alzheimers Drugs Market 2012-2016

Global Alzheimers Drugs Market 2012-2016

Category : Healthcare

------------ Or -------------

TechNavio's analysts forecast the Global Alzheimer's Drugs market to grow at a CAGR of 3.26 percent over the period 2012–2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Alzheimer's Drugs market has also been witnessing the availability of improved diagnostics. However, numerous patent expiries could pose a challenge to the growth of this market. 

TechNavio's report, the Global Alzheimer's Drugs market 2012–2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Alzheimer’s Drugs market in the Americas, the EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space include Eisai Co., Ltd., Forest Laboratories Inc., H. Lundbeck A/S., Novartis AG, and Pfizer Inc.

Key questions answered in this report: 
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

4.1. Market Research Process

4.2. Research Design

4.3. Research Methodology

5. Scope of the Report

5.1. Market Overview

5.2. Product Offerings

5.3. Product Profiles

6. Market Landscape

6.1. Global Alzheimer's Drugs market 2012–2016 

6.1.1. Market Size and Forecast 

6.1.2. Market Size and Forecast  For EU

7. Five Force Analysis

8. Geographical Segmentation

9. Rate of Incidence and Prevalence

10. Vendor Landscape

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Key Vendor Analysis

17.1. Forest Laboratories Inc.

17.1.1. Business Overview

17.1.2. Key Information

17.1.3. SWOT Analysis

17.2. Eisai Co., Ltd.

17.2.1. Business Overview

17.2.2. Key Information

17.2.3. SWOT Analysis

17.3. Novartis AG

17.3.1. Business Overview

17.3.2. Key Information

17.3.3. SWOT Analysis

17.4. H. Lundbeck A/S

17.4.1. Business Overview

17.4.2. Key Information

17.4.3. SWOT Analysis

17.5. Pfizer Inc.

17.5.1. Business Overview

17.5.2. Key Information

17.5.3. SWOT Analysis

18. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology

Exhibit 2: Global Alzheimer's Drugs Market 2012–2016 (US$ billion)

Exhibit 3: Alzheimer's Drugs Market in the EU 2012-2016 (US$ billion)

Exhibit 4: Global Alzheimer’s Drugs Market by Geographical Segmentation   2012

Enquiry Before Buy